Immunotherapies for food allergy: Exploring new targets and innovative strategies for enhanced efficacy
DOI:
https://doi.org/10.46542/pe.2024.243.266272Keywords:
Clinical endpoint, Food allergy, Immunotherapy, Personalised treatmentAbstract
Food allergy is a growing public health concern. It affects children and adults, resulting in significant declines in the overall quality of life. In most cases, individuals must avoid consuming allergenic foods, which can be challenging, especially for patients who experience life-threatening symptoms even with minimal exposure to allergens. This review aimed to identify promising targets for immunotherapy in food allergy, strategies to reduce adverse reactions and side effects, optimal dosing approaches, clinical endpoints to measure efficacy, patient subgroups that benefit, and barriers to implementing immunotherapy. An in-depth literature review was conducted using PubMed and Google Scholar to look into novel approaches and possible targets for enhancing the effectiveness of immunotherapy. Targeting specific immune cells and molecules (e.g., IgE and Tregs), lowering the doses of allergens, extending intervals between doses, personalising dosing, selecting eligible patients carefully, and validating clinical endpoints have shown promising results in overcoming food allergy challenges and increasing immunotherapy efficacy. Potential innovative strategies to enhance immunotherapy efficacy encompass developing more cost-effective approaches, increasing access to trained specialists, developing standardised protocols, and collecting long-term data.
References
Aarestrup, F. M., Taketomi, E. A., Galvão, C. E. S., Gagete, E., Arruda, A. C. N. M., Alves, G. B., Lira, G. V. de A. G., Gonçalves, M. R., Miziara, M. G. C., & Casado, S. S. M. (2022). Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology–ASBAI. World Allergy Organization Journal, 15(10), 100697. https://doi.org/10.1016/j.waojou.2022.100697
Alvaro‐Lozano, M., Akdis, C. A., Akdis, M., Alviani, C., Angier, E., Arasi, S., Arzt‐Gradwohl, L., Barber, D., Bazire, R., & Cavkaytar, O. (2020). Allergen immunotherapy in children user’s guide. Pediatric Allergy and Immunology, 31, 1–101. https://doi.org/10.1111/pai.13189
Anagnostou, A. (2021). Weighing the benefits and risks of oral immunotherapy in clinical practice. Allergy and Asthma Proceedings, 42(2), 118. https://doi.org/10.2500/aap.2021.42.200107
Anderson, B., Wong, L., Adlou, B., Long, A., & Chinthrajah, R. S. (2021). Oral immunotherapy in children: Clinical considerations and practical management. Journal of Asthma and Allergy, 1497–1510. https://doi.org/10.2147/JAA.S282696
Arasi, S., Corsello, G., Villani, A., & Pajno, G. B. (2018). The future outlook on allergen immunotherapy in children: 2018 and beyond. Italian Journal of Pediatrics, 44(1), 1–9. https://doi.org/10.1186/s13052-018-0519-4
Bellinghausen, I., Khatri, R., & Saloga, J. (2022). Current strategies to modulate regulatory T cell activity in allergic inflammation. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.912529
Boden, S. R., & Wesley Burks, A. (2011). Anaphylaxis: A history with emphasis on food allergy. Immunological Reviews, 242(1), 247–257. https://doi.org/10.1111/j.1600-065X.2011.01028.x
Breiteneder, H., Peng, Y., Agache, I., Diamant, Z., Eiwegger, T., Fokkens, W. J., Traidl‐Hoffmann, C., Nadeau, K., O’Hehir, R. E., & O’Mahony, L. (2020). Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy, 75(12), 3039–3068. https://doi.org/10.1111/all.14582
Canonica, G. W., Bachert, C., Hellings, P., Ryan, D., Valovirta, E., Wickman, M., De Beaumont, O., & Bousquet, J. (2015). Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report. World Allergy Organization Journal, 8(1), 1–10. https://doi.org/10.1186/s40413-015-0079-7
Chang, C., & Sun, Y. (2022). Global Strategy for asthma management and prevention: Interpretation of the Updates in 2022. Chinese General Practice, 25(35), 4355. https://doi.org/10.12114/j.issn.1007-9572.2022.0554
El Mecherfi, K.-E., Todorov, S. D., Cavalcanti de Albuquerque, M. A., Denery-Papini, S., Lupi, R., Haertlé, T., Dora Gombossy de Melo Franco, B., & Larré, C. (2020). Allergenicity of fermented foods: emphasis on seeds protein-based products. Foods, 9(6), 792. https://doi.org/10.3390/foods9060792
Feuille, E., & Nowak-Wegrzyn, A. (2018). Allergen-specific immunotherapies for food allergy. Allergy, Asthma & Immunology Research, 10(3), 189–206. https://doi.org/10.4168/aair.2018.10.3.189
Galli, S. J., & Tsai, M. (2012). IgE and mast cells in allergic disease. Nature Medicine, 18(5), 693–704. https://doi.org/10.1038/nm.2755
Hadley, C. (2006). Food allergies on the rise? Determining the prevalence of food allergies, and how quickly it is increasing, is the first step in tackling the problem. EMBO Reports, 7(11), 1080–1083. https://doi.org/10.1038/sj.embor.7400846
Hwang, D. W., Nagler, C. R., & Ciaccio, C. E. (2022). New and emerging concepts and therapies for the treatment of food allergy. Immunotherapy Advances, 2(1), ltac006. https://doi.org/10.1093/immadv/ltac006
Iweala, O. I., Choudhary, S. K., & Commins, S. P. (2018). Food allergy. Current Gastroenterology Reports, 20(5), 1–6. https://doi.org/10.1007/s11894-018-0624-y
Kowalski, M. L., Ansotegui, I., Aberer, W., Al-Ahmad, M., Akdis, M., Ballmer-Weber, B. K., Beyer, K., Blanca, M., Brown, S., & Bunnag, C. (2016). Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organization Journal, 9, 1–42. https://doi.org/10.1186/s40413-016-0122-3
Liu, G., Liu, M., Wang, J., Mou, Y., & Che, H. (2021). The role of regulatory T cells in epicutaneous immunotherapy for food allergy. Frontiers in Immunology, 12, 660974. https://doi.org/10.3389/fimmu.2021.660974
Lloyd, M., Galvin, A. D., & Tang, M. L. K. (2022). Measuring the impact of food immunotherapy on health-related quality of life in clinical trials. Frontiers in Allergy, 3. https://doi.org/10.3389/falgy.2022.941020
Lopez, C. M., Yarrarapu, S. N. S., & Mendez, M. D. (2023). Food allergies. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK482187/
Magnan, A., Nicolas, J.-F., Caimmi, D., Vocanson, M., Haddad, T., Colas, L., Scurati, S., Mascarell, L., & Shamji, M. H. (2023). Deciphering differential behavior of immune responses as the foundation for precision dosing in allergen immunotherapy. Journal of Personalized Medicine, 13(2), 324. https://doi.org/10.3390/jpm13020324
Moote, W., Kim, H., & Ellis, A. K. (2018). Allergen-specific immunotherapy. Allergy, Asthma, and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology, 14(Suppl 2), 53. https://doi.org/10.1186/s13223-018-0282-5
Muraro, A., de Silva, D., Halken, S., Worm, M., Khaleva, E., Arasi, S., Dunn-Galvin, A., Nwaru, B. I., De Jong, N. W., & Del Río, P. R. (2022a). Managing food allergy: GA2LEN guideline 2022. World Allergy Organization Journal, 15(9), 100687. https://doi.org/10.1016/j.waojou.2022.100687
Muraro, A., Tropeano, A., & Giovannini, M. (2022b). Allergen immunotherapy for food allergy: Evidence and outlook. Allergologie Select, 6, 285. https://doi.org/10.5414/ALX02319E
Palomares, O., Elewaut, D., Irving, P. M., Jaumont, X., & Tassinari, P. (2022). Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity? Allergy, 77(11), 3293–3308. https://doi.org/10.1111/all.15449
Pechsrichuang, P., & Jacquet, A. (2020). Molecular approaches to allergen‐specific immunotherapy: Are we so far from clinical implementation? Clinical & Experimental Allergy, 50(5), 543–557. https://doi.org/10.1111/cea.13588
Pitsios, C., Petalas, K., Dimitriou, A., Parperis, K., Gerasimidou, K., & Chliva, C. (2022). Workup and clinical assessment for allergen immunotherapy candidates. Cells, 11(4), 653. https://doi.org/10.3390/cells11040653
Schoos, A.-M. M., Bullens, D., Chawes, B. L., Costa, J., De Vlieger, L., DunnGalvin, A., Epstein, M. M., Garssen, J., Hilger, C., & Knipping, K. (2020). Immunological outcomes of allergen-specific immunotherapy in food allergy. Frontiers in Immunology, 11, 568598. https://doi.org/10.3389/fimmu.2020.568598
Scurlock, A. M., & Jones, S. M. (2010). An update on immunotherapy for food allergy. Current Opinion in Allergy and Clinical Immunology, 10(6), 587.
Sim, K., Mijakoski, D., Stoleski, S., Del Rio, P. R., Sammut, P., Le, T.-M., Munblit, D., & Boyle, R. J. (2020). Outcomes for clinical trials of food allergy treatments. Annals of Allergy, Asthma & Immunology, 125(5), 535–542. https://doi.org/10.1097/ACI.0b013e32833fd5eb
Song, T. W. (2016). A practical view of immunotherapy for food allergy. Korean Journal of Pediatrics, 59(2), 47. https://doi.org/10.3345/kjp.2016.59.2.47
Tontini, C., & Bulfone-Paus, S. (2021). Novel approaches in the inhibition of IgE-induced mast cell reactivity in food allergy. Frontiers in Immunology, 12, 613461. https://doi.org/10.3389/fimmu.2021.613461
Turner, P. J., Baumert, J. L., Beyer, K., Boyle, R. J., Chan, C., Clark, A. T., Crevel, R. W. R., DunnGalvin, A., Fernández‐Rivas, M., & Gowland, M. H. (2016). Can we identify patients at risk of life‐threatening allergic reactions to food? Allergy, 71(9), 1241–1255. https://doi.org/10.1111/all.12924
Warren, C. M., Jiang, J., & Gupta, R. S. (2020). Epidemiology and burden of food allergy. Current Allergy and Asthma Reports, 20, 1-9. https://doi.org/10.1007/s11882-020-0898-7
Westwell‐Roper, C., To, S., Andjelic, G., Lu, C., Lin, B., Soller, L., Chan, E. S., & Stewart, S. E. (2022). Food‐allergy‐specific anxiety and distress in parents of children with food allergy: A systematic review. Pediatric Allergy and Immunology, 33(1), e13695. https://doi.org/10.1111/pai.13695
Yu, W., Freeland, D. M. H., & Nadeau, K. C. (2016). Food allergy: Immune mechanisms, diagnosis and immunotherapy. Nature Reviews Immunology, 16(12), 751–765. https://doi.org/10.1038/nri.2016.111
Zhernov, Y., Curin, M., Khaitov, M., Karaulov, A., & Valenta, R. (2019). Recombinant allergens for immunotherapy: State of the art. Current Opinion in Allergy and Clinical Immunology, 19(4), 402. https://doi.org/10.1097/ACI.0000000000000536
